A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
WhiteOak Capital Pharma and Healthcare Fund
Regular
Direct
2 Year Absolute Returns
31.24% ↑
NAV (₹) on 02 Apr 2026
13.21
1 Day NAV Change
-1.03%
Risk Level
Very High Risk
Rating
-
WhiteOak Capital Pharma and Healthcare Fund is a Equity mutual fund categorized under Sector, offered by WhiteOak Capital Asset Management Ltd.. Launched on 16 Jan 2024, investors can start with a ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
16 Jan 2024
Min. Lumpsum Amount
₹ 500
Fund Age
2 Yrs
AUM
₹ 533.05 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
2.37%
Scheme Type
Open Ended
Exit Load
1%
Asset Allocation
AUM
₹ 533.05 Cr
Equity
187.74%
Debt
5.06%
Money Market & Cash
5.74%
Other Assets & Liabilities
1.46%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 61.39% |
| Hospitals & Medical Services | 27.34% |
| Treps/Reverse Repo | 2.99% |
| Others - Not Mentioned | 2.42% |
| Plastics - Plastic & Plastic Products | 1.78% |
| Chemicals - Others | 1.60% |
| Chemicals - Speciality | 1.46% |
| Net Receivables/(Payables) | 0.73% |
| Medical Equipment & Accessories | 0.29% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 11.85% | ₹ 63.15 | Pharmaceuticals |
| JB Chemicals & Pharmaceuticals Limited | 9.44% | ₹ 50.34 | Pharmaceuticals |
| Max Healthcare Institute Limited | 5.88% | ₹ 31.33 | Hospitals & Medical Services |
| Fortis Healthcare Limited | 5.54% | ₹ 29.54 | Hospitals & Medical Services |
| Lupin Limited | 5.29% | ₹ 28.18 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 5.08% | ₹ 27.08 | Hospitals & Medical Services |
| Divi's Laboratories Limited | 4.74% | ₹ 25.27 | Pharmaceuticals |
| Laurus Labs Limited | 4.33% | ₹ 23.06 | Pharmaceuticals |
| Krishna Institute Of Medical Sciences Limited | 3.95% | ₹ 21.06 | Hospitals & Medical Services |
| Clearing Corporation of India Ltd | 2.99% | ₹ 15.92 | Others |
| Sai Life Sciences Limited | 2.46% | ₹ 13.14 | Pharmaceuticals |
| Ajanta Pharma Limited | 2.35% | ₹ 12.52 | Pharmaceuticals |
| Corona Remedies Limited | 2.31% | ₹ 12.32 | Pharmaceuticals |
| Acutaas Chemicals Limited | 2.25% | ₹ 12.01 | Pharmaceuticals |
| IPCA Laboratories Limited | 1.96% | ₹ 10.46 | Pharmaceuticals |
| Narayana Hrudayalaya Limited | 1.94% | ₹ 10.32 | Hospitals & Medical Services |
| Shaily Engineering Plastics Limited | 1.78% | ₹ 9.51 | Plastics - Plastic & Plastic Products |
| Pfizer Limited | 1.73% | ₹ 9.23 | Pharmaceuticals |
| Emcure Pharmaceuticals Limited | 1.70% | ₹ 9.05 | Pharmaceuticals |
| Navin Fluorine International Limited | 1.60% | ₹ 8.52 | Chemicals - Others |
| AstraZeneca Pharma India Limited | 1.48% | ₹ 7.88 | Pharmaceuticals |
| Neuland Laboratories Limited | 1.46% | ₹ 7.78 | Pharmaceuticals |
| Kovai Medical Center and Hospital Limited | 1.32% | ₹ 7.03 | Hospitals & Medical Services |
| Aurobindo Pharma Limited | 1.32% | ₹ 7.02 | Pharmaceuticals |
| Aether Industries Limited | 1.26% | ₹ 6.73 | Chemicals - Speciality |
| Strides Pharma Science Limited | 1.18% | ₹ 6.27 | Pharmaceuticals |
| Dr. Lal Path Labs Limited | 1.17% | ₹ 6.26 | Hospitals & Medical Services |
| Vijaya Diagnostic Centre Limited | 1.14% | ₹ 6.10 | Hospitals & Medical Services |
| Thyrocare Technologies Limited | 0.99% | ₹ 5.28 | Hospitals & Medical Services |
| 91 Days Tbill (MD 22/05/2026) | 0.93% | ₹ 4.94 | Others - Not Mentioned |
| Supriya Lifescience Limited | 0.84% | ₹ 4.46 | Pharmaceuticals |
| Sudeep Pharma Limited | 0.75% | ₹ 4.02 | Pharmaceuticals |
| 91 Days Tbill (MD 12/03/2026) | 0.75% | ₹ 3.99 | Others - Not Mentioned |
| Net Receivables / (Payables) | 0.73% | ₹ 3.94 | Others |
| Zota Health Care Limited | 0.66% | ₹ 3.50 | Pharmaceuticals |
| Aarti Pharmalabs Limited | 0.61% | ₹ 3.25 | Pharmaceuticals |
| Abbott India Limited | 0.58% | ₹ 3.10 | Pharmaceuticals |
| Alkem Laboratories Limited | 0.54% | ₹ 2.90 | Pharmaceuticals |
| Shilpa Medicare Limited | 0.52% | ₹ 2.78 | Pharmaceuticals |
| Zydus Lifesciences Limited | 0.49% | ₹ 2.62 | Pharmaceuticals |
| Dr.Agarwals Eye Hospital Limited | 0.33% | ₹ 1.78 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Limited | 0.29% | ₹ 1.55 | Pharmaceuticals |
| Poly Medicure Limited | 0.29% | ₹ 1.55 | Medical Equipment & Accessories |
| Orchid Pharma Limited | 0.26% | ₹ 1.38 | Pharmaceuticals |
| Tatva Chintan Pharma Chem Limited | 0.20% | ₹ 1.07 | Chemicals - Speciality |
| 364 Days Tbill (MD 19/03/2026) | 0.19% | ₹ 1 | Others - Not Mentioned |
| 364 Days Tbill (MD 07/05/2026) | 0.19% | ₹ 0.99 | Others - Not Mentioned |
| 91 Days Tbill (MD 14/05/2026) | 0.19% | ₹ 0.99 | Others - Not Mentioned |
| 182 Days Tbill (MD 19/03/2026) | 0.13% | ₹ 0.70 | Others - Not Mentioned |
| 182 Days Tbill (MD 09/04/2026) | 0.04% | ₹ 0.20 | Others - Not Mentioned |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -2.23% | 4.90% | 14.56% | - |
| Category returns | -7.38% | 1.10% | 4.40% | 20.04% |
Fund Objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there ... Read more
AMC Details
Name
WhiteOak Capital Asset Management Ltd.
Date of Incorporation
03 Jul 2018
CEO
Mr. Aashish P Somaiyaa
CIO
Mr. Ramesh Mantri
Type
Pvt.Sector-Indian
Address
Unit No. B4, 6th Floor, Cnergy,
Appasaheb Marathe Marg,
Prabhadevi, Mumbai, Maharashtra, India - 400025
Website
https://mf.whiteoakamc.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹110.58 | -6.78% | 32.14% | 68.19% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹110.58 | -6.78% | 32.14% | 68.19% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹183.63 | -6.78% | 32.14% | 68.18% | ₹4,273 | 1.92% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹14.90 | 4.00% | 31.81% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹14.90 | 4.00% | 31.81% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
DSP Quant Fund - Direct Plan
Largecap
Direct
|
₹20.71 | -0.11% | 31.80% | 44.78% | ₹838 | 0.55% |
Very High
|
|
HSBC Infrastructure Fund
Sector
Regular
|
₹31.33 | -7.57% | 31.57% | 70.85% | ₹2,300 | 2.06% |
Very High
|
Top Funds from WhiteOak Capital Asset Management Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
WhiteOak Capital Ultra Short Duration Fund
Liquid
Regular
|
₹1,007.44 | -0.10% | 0.26% | 0.46% | ₹560 | 1.02% |
Low to Moderate
|
|
WhiteOak Capital Ultra Short Duration Fund
Liquid
Regular
|
₹1,007.44 | -0.10% | 0.26% | 0.46% | ₹560 | 1.02% |
Low to Moderate
|
|
WhiteOak Capital Ultra Short Duration Fund - Direct Plan
Liquid
Direct
|
₹1,471.42 | 6.20% | 22.54% | 34.28% | ₹560 | 0.52% |
Low to Moderate
|
|
WhiteOak Capital Liquid Fund - Direct Plan
Liquid
Direct
|
₹1,004.83 | 0.13% | 0.21% | 0.41% | ₹604 | 0.19% |
Low to Moderate
|
|
WhiteOak Capital Liquid Fund - Direct Plan
Liquid
Direct
|
₹1,004.83 | 0.13% | 0.21% | 0.41% | ₹604 | 0.19% |
Low to Moderate
|
|
WhiteOak Capital Liquid Fund - Direct Plan
Liquid
Direct
|
₹1,477.55 | 6.22% | 22.20% | 32.86% | ₹604 | 0.19% |
Low to Moderate
|
|
WhiteOak Capital Liquid Fund
Liquid
Regular
|
₹1,467.62 | 6.11% | 21.83% | 32.20% | ₹604 | 0.31% |
Low to Moderate
|
|
WhiteOak Capital Ultra Short Duration Fund
Liquid
Regular
|
₹1,415.77 | 5.64% | 20.50% | 30.45% | ₹560 | 1.02% |
Low to Moderate
|
|
WhiteOak Capital Liquid Fund
Liquid
Regular
|
₹1,004.90 | 0.10% | 0.18% | 0.36% | ₹604 | 0.31% |
Low to Moderate
|
|
WhiteOak Capital Liquid Fund
Liquid
Regular
|
₹1,004.90 | 0.10% | 0.18% | 0.36% | ₹604 | 0.31% |
Low to Moderate
|
FAQs
What is the current NAV of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
The current Net Asset Value (NAV) of WhiteOak Capital Pharma and Healthcare Fund Regular Growth is ₹13.21 as of 02 Apr 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
The Assets Under Management (AUM) of WhiteOak Capital Pharma and Healthcare Fund Regular Growth is ₹533.05 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
WhiteOak Capital Pharma and Healthcare Fund Regular Growth has delivered returns of 4.90% (1 Year), 0.00% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
WhiteOak Capital Pharma and Healthcare Fund Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
The minimum lumpsum investment required for WhiteOak Capital Pharma and Healthcare Fund Regular Growth is ₹500. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
The Best Way To Build A Mutual Fund Portfolio In Your 20s, 30s And 40s -
How To Gift Mutual Funds To Children: Rules, Tax Implications And Process Explained -
How to Position Portfolio Amid Global Tensions, Rising Gold,Silver ETF Inflows? Navi CEO Aditya Mulki Explains -
NPS vs Mutual Funds For Retirement: Which Investment Option Offers Better Growth, Tax Benefits And Stability? -
Big Shake-Up in Mutual Funds! SEBI Scraps Solution Funds, Introduces Life-Cycle Category | 5 Changes Explained -
Selling Mutual Funds? Here’s How You Can Save Capital Gains Tax Under Section 54F -
What Are Multi-Cap Mutual Funds? Single Fund Exposure to Large, Mid and Small-Cap Stocks; Know Details -
Can UAE-Based NRIs Invest In Indian Mutual Funds? Rules, Taxes And DTAA Explained -
What Is A Balanced Advantage Fund (BAF) And How Does It Work? -
Are Retirement Mutual Funds The Right Choice For Long-Term Investment Planning?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+